Friday, October 16, 2015
Supplements blamed for 23,000 ER visits in US each year
MIAMI -- Over the counter supplements, including vitamins, sexual enhancements and weight loss aids, are being blamed for 23,000 visits to US emergency rooms each year, according to a decade-long study this week.
The findings published in the New England Journal of Medicine are based on reports from a nationally representative sample of 63 emergency departments from 2004 through 2013.
The study raised new concerns among experts over the safety of an industry that critics say is largely unregulated and yet highly popular among consumers -- bringing in $14.8 billion in 2007, or one third of the out-of-pocket expenditures for prescription drugs, according to background information in the article.
More than one quarter (28 percent) of visits were by adults aged 20 to 34.
Weight loss aids were a leading culprit in this age group, causing more than half of emergency room visits, commonly for heart related symptoms including palpitations, chest pain, or irregular heartbeat.
More than one fifth (21 percent) of emergency visits were due to children swallowing supplements.
"Child-resistant packaging is not required for dietary supplements other than those containing iron, and despite such packaging, iron supplements were the second most commonly implicated type of supplement in unsupervised ingestion by children," said the study.
When it came to people, swallowing problems caused nearly 40 percent of emergency department visits for supplement-related adverse events.
Just 2,000 people are hospitalized annually after taking supplements.
The research did not track any deaths that might have been linked to supplement use.
The study pointed out that although the US Food and Drug Administration is tasked with overseeing supplements, "neither safety testing nor FDA approval is required before the marketing of dietary supplements."
The researchers also said their estimates are likely lower than the actual number because patients do not always report using supplements.
The Council for Responsible Nutrition, an industry group, said the findings should be viewed in context, and defended the safety of supplements.
"The results of this study reinforce that dietary supplements are safe products, particularly when put into context with the number of people -- over 150 million Americans -- who take dietary supplements every year," said Duffy MacKay, senior vice president of scientific and regulatory affairs.
"To put this projected number of 23,000 annual emergency room (ER) visits into context, we estimate that far less than one tenth of one percent of dietary supplement users experience an emergency room visit annually."
source: interaksyon.com
Tuesday, February 17, 2015
Anti-smoking drug helps reluctant quitters: study
A medication known as varenicline (Chantix) has been shown to help some smokers quit, even if they were not ready to give up cigarettes right away, international researchers said Tuesday.
The study in the Journal of the American Medical Association (JAMA) was funded by pharmaceutical giant Pfizer, which makes Chantix, but was led by doctors at the non-profit Mayo Clinic in Rochester, Minnesota.
More than 1,500 smokers enrolled. All said they were not ready to quit in the next 30 days, but did want to kick the habit within three months.
Researchers randomly assigned some to receive the drug for six months and others to receive a placebo.
After six months, those who received varenicline were more than four times more likely to quit than those who took a sugar pill -- 32.1 percent on the medication stopped smoking, compared to 6.9 percent of the placebo group.
After a year, those in the medication group were twice as likely to have quit than those in the placebo cohort. By that time, 27 percent on the medication had quit, versus 9.9 percent on the placebo.
The drug comes with side effects, ranging from nausea to thoughts of suicide, and did not help most of the smokers quit.
But researchers said their analysis showed it was more helpful than a placebo when it came to long-term habit changes.
"This study is important because this opens the door to treatment for approximately 14 million smokers who have no intention of quitting in the next 30 days but are willing to reduce their smoking rate while working toward a quit attempt," said lead author Jon Ebbert, associate director for research in the Mayo Clinic Nicotine Dependence Center.
"Smokers should know that varenicline can help them quit smoking if they want to reduce their smoking prior to completely stopping," he added.
"It's an effective and safe way to increase long-term smoking cessation."
Co-authors on the study came from the University of Vermont, University of London and Nebraska Medical Center.
source: interaksyon.com
Thursday, November 14, 2013
DOH orders price freeze on 200 essential medicines for Yolanda victims
MANILA, Philippines - Health Secretary Enrique Ona has ordered a price freeze on about 200 essential medicines nationwide to ensure the availability of supplies for the victims of super typhoon Yolanda (international code name: Haiyan).
The price freeze takes effect immediately and covers all public and private drug outlets, including hospital pharmacies.
Ona has encouraged consumers to lodge their complaints against any violation, as he warned drug manufacturers, traders and retailers to strictly implement the order.
He said a price freeze “means that suppliers, pharmacies and hospitals should not unduly hike the prices of essential drugs from their prevailing prices before the occurrence of the calamity.”
“Securing the health and safety of the typhoon victims is an immediate priority of the DOH (Department of Health). We have to make sure that they have access to the medicines that they need and that public hospitals and government agencies are able to source affordable drugs to reach as many of our countrymen severely affected by this crisis,” he said.
The essential drugs are for physical and mental trauma and injury, diarrhea, pneumonia, skin diseases and other infections such as leptospirosis and other endemic diseases in affected areas.
Other essential drugs covered by the price freeze include those that address common chronic diseases such as diabetes, hypertension and asthma that are “likely to be aggravated by the anxiety and stress as well as the difficult conditions faced on a daily basis by the victims”
The DOH fears an increase in many diseases due to the lack of clean water and food; breakdown in water and sanitation facilities; the severe state of primary health facilities and the continued harsh conditions in the Yolanda-affected areas.
The Price Act (Republic Act 7581) mandates the DOH to “automatically freeze the prices of essential drugs classified as basic commodities or impose maximum price ceilings particularly in times of calamities to protect consumers from profiteering, hoarding, cartels and other such violations by traders who may take advantage of the calamity situation.”
Ona has tasked all DOH regional directors to monitor the prices of essential drugs and make sure there is no overpricing especially in calamity-stricken areas.
source: interaksyon.com
Tuesday, October 29, 2013
Gym not for you? Easy home tasks also help heart - study
PARIS - Mowing the lawn or washing the car are among simple activities that can reduce the risk of heart attack or stroke by almost 30 percent in people over 60, researchers said Tuesday.
A study in Sweden found that older people who were physically active around the house stayed healthier longer than couch potatoes -- regardless of whether they also did any kind of "formal" exercise like jogging or going to the gym.
"A generally active daily life was, regardless of exercising regularly or not, associated with cardiovascular health and longevity in older adults," said the study in the British Journal of Sports Medicine.
While the health risks of prolonged sitting and the benefits of regular exercise have both been well documented, the contribution to good health of "non-exercise physical activity (NEPA)" is not fully understood.
For the study, researchers screened nearly 4,000 Swedish 60-year-olds in 1997-99 and tracked their health for an average 12.5 years.
The participants recorded how frequently they performed certain activities, including doing home repairs, cutting the lawn or hedge, car maintenance, going hunting or fishing, cycling, and gathering mushrooms or berries.
The researchers found that people with high levels of physical activity, excluding formal exercise, had a 27 percent lower risk of contracting cardiovascular disease compared with inactive people, and a 30 percent lower risk of death from all causes during the study period.
The results were "not significantly different" from those for people who did do regular formal exercise but had low NEPA levels, the study said.
Those who did both had the lowest risk.
"Promoting everyday NEPA might be as important as recommending regular exercise for older adults" -- boosting individual and population health as the demographic shifts towards an ever-older population in many parts of the world, the study said.
The researchers factored in other lifestyle factors that could influence the results, including alcohol intake, education level, smoking habits, and diet.
And they warned that care should be taken applying the findings in cultures that may have different physical activity habits and levels.
source: interaksyon.com
Thursday, September 19, 2013
Colonoscopies could reduce cancer risk by 40 percent
WASHINGTON DC - A colonoscopy every 10 years could prevent 40 percent of colorectal cancers, according a massive US study out Wednesday, supporting the effectiveness of the commonly-used test.
Those with family history of these types of cancer -- the second-leading cause of cancer deaths in the US -- should have more frequent screenings, the study in the New England Journal of Medicine said.
The results confirm the current recommendations for colonoscopies, offering evidence it is particularly useful in preventing cancers that originate in the proximal, or upper, part of the colon.
"Our study provides strong evidence that colonoscopy is an effective technique for preventing cancers of both distal and proximal regions of the colorectum," said Shuji Ogino, a lead author from the Havard School of Public Health.
The screening is crucial in preventing proximal cancers, he explained, because another test, called sigmoidoscopy, uses a scope to examine only the lower part of the colon and "alone is insufficient for preventing proximal cancer."
Unlike sigmoidoscopy, a colonoscopy examines the entire colon, using a camera-equipped device that also has tools to remove cysts and benign tumors.
The authors analyzed data from nearly 89,000 participants in two long-term studies, basing their conclusions on surveys completed every two years between 1988 and 2008.
The researchers also obtained information on any colonoscopies and sigmoidoscopies conducted. They documented 1,815 cases of colorectal cancer and 474 resulting deaths.
They found that both screenings reduced the risk of developing, or dying from, colorectal cancers.
But only the more complete, colonoscopy screening reduced the risk of cancers in the upper part of the colon -- though even still, its effects were less successful than for preventing lower bowel cancers.
They estimated that, if all the participants had undergone a colonoscopy, the overall risk of colorectal cancers would have been reduced by 40 percent -- preventing 61 percent of lower colon cancers and just 22 percent of upper colon cancers.
The researchers speculated there may be molecular or biological differences between upper and lower colon cancers behind the lower success rate.
source: interaksyon.com
Saturday, September 7, 2013
Human trials begin for anti-skin cancer vaccine
WASHINGTON - An experimental vaccine implant to treat skin cancer has begun early trials in humans, as part of a growing effort to train the immune system to fight tumors, researchers said Friday.
The approach, which was shown to work in lab mice in 2009, involves placing a fingernail-sized sponge under the skin where it reprograms a patient's immune cells to find cancerous melanoma cells and kill them.
"It is rare to get a new technology tested in the laboratory and moved into human clinical trials so quickly," said Glenn Dranoff, professor of medicine at Harvard Medical School and part of the research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
The phase I trial aims to test the safety of the implant in a small number of human patients. After that, the device may move to phase II trials on effectiveness and larger phase III trials before reaching the market.
The implants are made of biodegradable polymer material that are highly permeable and contain antigens that are specific to the kind of tumor being targeted.
The device releases a protein that attracts immune cells and sends them out armed to hunt down and kill tumor cells.
Researchers say it works differently than conventional cancer vaccines -- which involve removing immune cells from the patient, reprogramming them to attack malignancies and reinjecting them -- because it works from inside the body.
One drug already on the market using the immune system against melanoma, called Yervoy, is made by Bristol Myers Squibb and was approved by US regulators in 2011.
Pharmaceutical giants Merck and Roche also have drugs that use the immune system to fight cancer in clinical trials.
British pharma giant GlaxoSmithKline suffered a blow this week when its phase III trial of vaccine candidate MAGE-A3 did not extend survival in melanoma patients who received the vaccine after their tumors were surgically removed.
source: interaksyon.com
Thursday, May 2, 2013
Researchers map genetic mutations in adult blood cancer
WASHINGTON DC - US researchers on Wednesday said they have identified virtually all of the major mutations that drive acute myeloid leukemia (AML), a fast-growing blood cancer in adults that often is difficult to treat.
The findings, published online in the journal New England Journal of Medicine, pave the way for developing better treatments for AML patients. They also could lead to ways to more accurately predict the severity of disease in individual patients.
"We now have a genetic playbook for this type of leukemia," says study co-leader Timothy Ley at the Washington University School of Medicine in St. Louis.
"We don't know all the rules yet, but we know all the major players. This information can help us begin to understand which patients need more aggressive treatment right up front and which can be treated effectively with standard chemotherapy."
The study included some 200 patients newly diagnosed with AML. The researchers sequenced the DNA of each patient's leukemia cells and compared the data to DNA from each patient's healthy cells. In this way, they found the mutations that only occurred in the cancer cells and contributed to the development and progression of AML in each patient.
Cancer cells in the AML patients had an average of 13 mutated genes, far fewer than the several hundred typically found in breast, lung, and other solid tumors, according to the study.
By studying a large number of AML cases, the scientists believe they have found nearly all of the major mutations that occur in patients with the disease.
source: interaksyon.com
Friday, March 22, 2013
Japanese researchers reach breakthrough in breast cancer regenerative medicine
TOKYO -- Japanese researchers have achieved a major breakthrough in regenerative medicine for breast cancer patients, Japanese news agency Jiji Press reported.
The researchers succeeded in having breast cancer patients recover what was lost after breast-conserving surgery, an operation to remove breast cancer and not breast itself by transplanting fat mixed with their own stem cells.
The achievement was made by a team of researchers led by Bin Nakayama, associate professor at Tottori University during clinical testing conducted between September and January on five women aged between 30 and 60 who underwent breast-conserving surgery.
Durng the tests, fat taken out of the patients' abdomen or hips and mixed with their stem cells was transplanted into where tumours and surrounding tissues were removed.
The researchers said that if only fat is transplanted, most of it is absorbed into the body and about 30 per cent of it remains as it does not have blood vessels.
Between 70 to 90 per cent of transplanted fat remained after blood vessels were newly formed in the fat.
Stem cells are apparently capable of helping bring blood vessels into fat from surrounding tissues, the researchers added.
According to the Japanese Breast Cancer Society, some 60,000 Japanese develop breast cancer a year with 60 per cent undergoing breast-conserving surgery.
source: interaksyon.com
Sunday, March 17, 2013
The stem cell miracle
The room was crowded. Christian Drapeau was going to speak on stem cells. He told us that the discovery of humans coming from a single cell called the stem cell happened decades ago but not much attention was paid until around 10 years ago when the focus slowly shifted to the stem cell. Stem cells are in our bodies manufactured by our bone marrow then released into our blood stream. There they begin to circulate. All our organs lose living cells day to day. As the stem cell circulates, other cells that are part of our organs release some kind of sticky liquid that catches the stem cells and converts them into cells needed for that organ. For example, if you had a heart attack, there is damage to the cells in your heart. They need replacing. When your bone marrow releases stem cells into your blood, the heart will reach for them and slowly repair the damage.
One of the reasons why it took them so long to discover this is because the stem cells immediately begin to look like heart cells so one cannot say – oh those are new cells made from stem cells. But they discovered a blue-green substance that helped the bone marrow manufacture and release more stem cells. This gave the new cells a blue-green color. Now they were able to track the movement of stem cells and claim that the new cells were created by the equally new stem cells. Stem cells are the body’s natural healing system.
It is difficult to say what organs stem cells repair because they repair anything that needs repair. But StemEnhance is not a miracle drug. It is made from algae from a lake in Oregon, which has been tested over the years and proven to make the body’s bone marrow release more stem cells. Then it is up to your body to heal itself wherever it needs healing.
When I started to take StemEnhance I felt increased energy maybe after ten days. Instead of dragging myself around in my pajamas I began to wake up cheerful, shower, get dressed and organize my day. This is the very least of the capsules’ effects. Many of my friends claim this same effect on them and add that their friends comment on how young they look. So they keep coming back for more.
But I also know someone who came because her neighbor had to be carried to the hospital once a month for a check up. They read my article written last November 24. Now the old man walks and opens the gate himself. A young man regularly gets for his father who is 84, in tremendous perpetual pain when he first came to see me. Now his father feels no more pain and goes to the mall to walk. However, everything takes time. You have to commit to taking at least three capsules a day.
My only son, who is 41, is extremely diabetic. At 41 he has had cataract operations. He takes a double dose of the pills daily. I asked him how he was. He said, “My sugar is still high but these days I can arrange three songs, compose two and write a jingle all in one day. I never could have done that before. Your pills give me energy.” Over time I am certain even his diabetes will go.
But there are obstacles. So many people asked Christian Drapeau why the medicine was so expensive. He said, “Why don’t you look at the other side? How much does it take us to harvest, manufacture and get here?” And he is right.
What is more expensive? Stem Cell Therapy that involves taking your bone marrow then doing something to it then injecting it back into you for a couple of million pesos or to buy a bottle that increases your stem cells? It depends on how much money you have. If you are very rich, of course, go all the way to Switzerland for your stem cell therapy. But if you are average then just take StemEnhance. It is not cheap enough for everybody but it is good enough for most people.
But I must share this story. One of our recent recruits is an integrative doctor, Dr. Chris Tengco, M.D. He has a medical degree, also studied alternative medicine, anthroposophy and something else. Mostly his patients are people with level 4 cancer and so far he has managed to heal most of them. That afternoon he presented us with two of his patients who were healed. What is his secret? He has a special formula, which he gives them intravenously and he asks them to drink StemEnhance.
Don’t you think that’s remarkable? I think that is truly excellent.
article source: philstar.com
Tuesday, February 26, 2013
Panel questions value of calcium, vitamin D pills
WASHINGTON (AP) — Popping calcium and vitamin D pills in hopes of strong bones? Healthy older women should not bother with relatively low-dose dietary supplements, say new recommendations from a U.S. government advisory group.
Both nutrients are crucial for healthy bones and specialists advise getting as much as possible from a good diet. The body also makes vitamin D from sunshine. If an older person has a vitamin deficiency or bone-thinning osteoporosis, doctors often prescribe higher-than-normal doses.
But for otherwise healthy postmenopausal women, adding modest supplements to their diet — about 400 international units of D and 1,000 milligrams of calcium — do not prevent broken bones but can increase the risk of kidney stones, the U.S. Preventive Services Task Force said Monday.
It is not clear if those doses offer bone protection if taken before menopause, or if they help men's bones, the guidelines said.
What about higher-dose supplements that have become more common recently? There's not enough evidence to tell if they would prevent fractures, either, in an otherwise healthy person, the panel concluded. It urged more research to settle the issue.
It's a confusing message considering that for years, calcium and vitamin D supplements have been widely considered an insurance policy against osteoporosis, with little down side to taking them.
"Regrettably, we don't have as much information as we would like to have about a substance that has been around a long time and we used to think we understood," said Dr. Virginia Moyer of the Baylor College of Medicine, who heads the task force. "Turns out, there's a lot more to learn."
The main caution: These recommendations aren't for people at high risk of weak bones, including older adults who have previously broken a bone and are at risk for doing so again, said Dr. Sundeep Khosla of the American Society for Bone and Mineral Research. Those people should consult a doctor, said Khosla, a bone specialist at the Mayo Clinic who wasn't part of the panel's deliberations.
Calcium and vitamin D work together, and you need a lifetime of both to build and maintain strong bones. Vitamin D also is being studied for possibly preventing cancer and certain other diseases, something that Monday's guidelines don't address and that other health groups have cautioned isn't yet proven.
For now, national standards advise the average adult to get about 1,000 mg of calcium, 1,300 for postmenopausal women, every day. For vitamin D, the goal is 600 IUs of vitamin D every day, moving to 800 after age 70, according to the Institute of Medicine, which set those levels in 2010. The nutrients can come from various foods, including orange juice fortified with calcium and D; dairy foods such as milk, yogurt and cheese; certain fish including salmon; and fortified breakfast cereals. Harder to measure is how much vitamin D the body also produces from sunshine.
Most people should get enough calcium from food, said Mayo's Khosla. But while he cautions against too high doses, he frequently tells his patients to take a multivitamin because it's harder to get vitamin D from food and during the winter.
While supplement science gets sorted out, the task force's Moyer advises healthy seniors to exercise — proven to shore up bones and good for the rest of the body, too.
source: philstar.com
Friday, October 5, 2012
US abortion rates plummet with free birth control
CHICAGO - Providing free birth control to women and teens in Missouri at high risk of unplanned pregnancies led to a drastic drop in abortion rates and teenage mothers, a study published Thursday found.
If the same results were replicated across the United States, free birth control could prevent 1,060,370 unplanned pregnancies and 873,250 abortions a year.
"The impact of providing no-cost birth control was far greater than we expected in terms of unintended pregnancies," said lead author Jeff Peipert of the Washington University School of Medicine.
A lack of access to reliable birth control is a major factor behind the three million unplanned pregnancies in the United States every year.
Previous studies have found that 49 percent of US pregnancies are unintended. Half result from a failure to use birth control while the other half are due to inconsistent or incorrect use of birth control and contraceptive failure.
President Barack Obama's landmark health reform expanded access by requiring insurance companies to eliminate 'co-pays' on birth control and other health services beginning in August.
But millions of women without insurance still have to pay for their birth control out of pocket.
The Contraceptive CHOICE Project, which was funded by the Susan Thompson Buffett Foundation, provided counseling and free birth control to 9,256 teenage girls and women in the St. Louis area from 2007 until 2011.
Abortion rates among those women were less than half the regional and national averages: just six per 1,000 participants compared with 20 per 1,000 women nationwide.
The rate of teenage birth among study participants was just 6.3 per 1,000 compared to 34.1 per 1,000 teenagers nationwide.
One reason for the significant improvement is because 75 percent of the women chose to use long-acting methods such as implants and intrauterine devices (IUDs), Peipert said.
These methods are more than 20 times more effective than birth control pills, patches or rings but have a significantly higher up-front cost.
Some doctors are also "overly restrictive," Peipert said, and will not provide IUDs or implants to young women or women who plan to have children at a later date.
The study found women who chose the long acting methods were happier and much more likely to stick with them.
Some 85 percent of the women who chose long acting methods were still using them a year later, while only 55 percent of the study participants who chose birth control pills did so.
"Contraception only works when you keep using it," Peipert told AFP. "There are gaps in people's contraceptive use and that's when they get pregnant."
Expanding the program to provide free birth control nationwide would be costly, but Peipert said it would cost far less than dealing with the consequences.
"We're already paying for unintended pregnancies," he said, noting that US taxpayers pay about $11 billion in costs associated with one million unplanned births every year.
The study was published in the journal Obstetrics and Gynecology.
It comes a couple weeks after the American College of Obstetricians and Gynecologists issued new guidelines recommending that doctors offer implants and IUDs to sexually active teenagers.
"These long-acting methods eliminate the problem of inconsistent use common with other contraceptives that can lead to unintended pregnancy," the college said, noting that complications from IUDs and implants are rare.
source: interaksyon.com
Saturday, August 11, 2012
Etsy blocks sales of drugs and human remains

NEW YORK (CNNMoney) -- Etsy has become the go-to spot for homemade jewelry, knickknacks and household goods. Apparently, some have also been using the online marketplace to sell everything from drugs to human remains.
Now Etsy is cracking down.
The online marketplace recently revised its policies, excluding from its list of sellable items such products as tobacco, hazardous materials and body parts. (Hair and teeth are still OK).
"Odd as it may sound, we've spent long hours over the past several months extensively researching some offbeat and fascinating topics, from issues surrounding the sale of human bones to the corrosive and toxic properties of mercury," the company wrote on its official blog on Wednesday.
Etsy says the changes are made in order to comply with legal rules and restrictions.
"But beyond that, when it comes right down to it, some things just aren't in the spirit of Etsy," the online company wrote. "While we understand that it is possible for certain items to be carefully and legally bought and sold, Etsy is just not the right venue for them."
The new policy prohibits the sale of human body parts, including but not limited to "things such as skulls, bones, articulated skeletons, bodily fluids, preserved tissues or organs, and other similar products."
Etsy banned most drug paraphernalia, though the company said it is not explicitly banning the sale of medical drugs. Instead, it's asking that sellers remove any claims of "cure or relief of a health condition or illness."
That set off a slew of angry posts from Etsy sellers in the company's public forums.
"Now I need to change near[ly] a quarter of my listings or remove them," wrote Etsy user Chrissy-jo, who operates an online store called KindredImages. "How am I going explain the use of a salve or even an aromatherapy eye pillow without making the claim that it aids in healing wounds or it helps relieve migraines?"
Another Etsy user named Irina, who runs PheonixBotanicals, wrote: "As an herbal crafter, I find the idea of being banned from listing traditional uses and folklore of plants quite disheartening."
Monday, August 6, 2012
Chemotherapy can backfire and boost cancer growth: study

PARIS -- Cancer-busting chemotherapy can cause damage to healthy cells which triggers them to secrete a protein that sustains tumour growth and resistance to further treatment, a study said Sunday.
Researchers in the United States made the "completely unexpected" finding while seeking to explain why cancer cells are so resilient inside the human body when they are easy to kill in the lab.
They tested the effects of a type of chemotherapy on tissue collected from men with prostate cancer, and found "evidence of DNA damage" in healthy cells after treatment, the scientists wrote in Nature Medicine.
Chemotherapy works by inhibiting reproduction of fast-dividing cells such as those found in tumours.
The scientists found that healthy cells damaged by chemotherapy secreted more of a protein called WNT16B which boosts cancer cell survival.
"The increase in WNT16B was completely unexpected," study co-author Peter Nelson of the Fred Hutchinson Cancer Research Center in Seattle told AFP.
The protein was taken up by tumour cells neighbouring the damaged cells.
"WNT16B, when secreted, would interact with nearby tumour cells and cause them to grow, invade, and importantly, resist subsequent therapy," said Nelson.
In cancer treatment, tumours often respond well initially, followed by rapid regrowth and then resistance to further chemotherapy.
Rates of tumour cell reproduction have been shown to accelerate between treatments.
"Our results indicate that damage responses in benign cells... may directly contribute to enhanced tumour growth kinetics," wrote the team.
The researchers said they confirmed their findings with breast and ovarian cancer tumours.
The result paves the way for research into new, improved treatment, said Nelson.
"For example, an antibody to WNT16B, given with chemotherapy, may improve responses (kill more tumour cells)," he said in an email exchange.
"Alternatively, it may be possible to use smaller, less toxic doses of therapy."
source: interaksyon.com
Wednesday, July 25, 2012
Researchers to test effectiveness of vaginal ring for HIV prevention
Two large clinical trials in Africa are ramping up to test the effectiveness of a vaginal ring that releases an HIV-fighting drug for a month or more, offering women at high risk a discreet way to protect themselves from the virus that causes AIDS.
The studies will test the effectiveness of a vaginal ring containing the antiretroviral drug dapivirine in thousands of women in several African countries to evaluate its ability to prevent new HIV infections and its long-term safety.
If effective, the ring will add "a long-acting, female-initiated technology to the existing toolkit of HIV prevention options," said Dr. Zeda Rosenberg, chief executive officer of International Partnership for Microbicides (IPM), a nonprofit group founded by Rosenberg which is developing the ring.
Because it only needs to be replaced once a month, the ring may help address some of the problems with getting women to consistently use vaginal gels each time they have sex, Rosenberg said during a briefing at the International AIDS Conference in Washington.
Irregular use is thought to be the reason a large study of the microbicidal gel containing the anti-HIV drug tenofovir failed to prevent infections in women in sub-Saharan Africa.
IPM has a royalty-free licensing agreement with Johnson & Johnson's Janssen unit in Ireland to use its dapivirine antiretroviral product in gel and ring forms to prevent HIV infections in low and middle income countries.
Dapivirine is part of a class of antiretroviral drugs that have long been used to treat HIV and prevent mother-to-child transmission of the virus.
NIH PARTNERSHIP
The IPM study will enroll 1,650 women aged 18 to 45, who will be randomly assigned to use the ring or a placebo in four sites in South Africa, with plans to expand to sites in Rwanda and Malawi.
It is being conducted in partnership with the U.S. National Institutes of Health-backed Microbicide Trials Network, which just started enrolling women in a separate trial called ASPIRE.
"Developing scientifically proven forms of HIV prevention that women can control is essential," said Dr. Anthony Fauci, director of the NIH's National Institute of Allergy and Infectious Disease.
"Because the vaginal ring is a long-acting intervention, it has a potential added benefit in that women may find it relatively easy to use."
The ASPIRE study will test the ring in 3,476 women aged 18 to 45 in Malawi, South Africa, Uganda, Zambia and Zimbabwe.
Women in the studies will be offered condoms and counseling on HIV prevention, and taught how to insert the vaginal ring. At monthly visits, researchers will keep track of whether women are still using the ring and give them a replacement.
Those women who become pregnant during the study will discontinue use of the ring, and their safety and that of their child will continue to be monitored.
Dr. Saidi Kapiga of the London School of Hygiene and Tropical Medicine, who is coordinating the ring study in Africa and has also conducted tests of vaginal gels for HIV protection, said there are already signs that women prefer the new option.
"It is acceptable," Kapiga told the briefing. "The fact that they use it only once in four weeks was a major advantage."
Both trials are designed to detect at least a 60 percent reduction in HIV risk, but researchers said they hope for even better results, which are expected in 2015.
"If proven to be effective, I think this will really revolutionize prevention for women," Dr. Sharon Hillier, who heads the Microbicide Trials Network at the University of Pittsburgh School of Medicine, told the briefing.
source: interaksyon.com
Friday, June 1, 2012
Medical Benefits Of Mangosteen Cited
MANILA, Philippines --- The sour mangosteen is also a medicine.
This argument was advanced recently by members of a religious congregation called the Handmaids of Christ the King or Ancillae Christi Regis (ACR) who have been collecting mangosteen peelings and manufacturing capsules from the rind, which some researchers insist teems with antioxidants. ACR, based in Tagum City, Davao del Norte, was recently visited by Agriculture Secretary Proceso J. Alcala, who also witnessed how the capsule is being manufactured in a two-storey house-cum-production facility that can be reached through a narrow road.
The congregation started producing mangosteen capsules two years ago by pounding dried mangosteen rind into powder in their ancient mortar and pestle.
After collecting the powder, they are placed into biodegradable capsules and packed for sale in outlets that specialize in organic preparations and wellness products.
The proceeds are plowed back to sustain the ACR herbal medicine processing facility and part of the cash is also used for charitable activities.
Sister Concordia Pingoy, ACR Superior General, said they are currently producing 100,000 mangosteen capsules a month that are sold at P3 each in oputlets located in Tagum City.
The ACR sisters also churn out malunggay and yellow ginger or turmeric capsules,
She said the demand for their herbal capsules is gradually picking up since those who had used them attest to their beneficial effects.
source: mb.com.ph
Thursday, May 31, 2012
For Some, Exercise May Increase Heart Risk

Could exercise actually be bad for some healthy people? A well-known group of researchers, including one who helped write the scientific paper justifying national guidelines that promote exercise for all, say the answer may be a qualified yes.
By analyzing data from six rigorous exercise studies involving 1,687 people, the group found that about 10 percent actually got worse on at least one of the measures related to heart disease:blood pressure and levels of insulin, HDL cholesterolortriglycerides. About 7 percent got worse on at least two measures. And the researchers say they do not know why.
“It is bizarre,” said Claude Bouchard, lead author of the paper, published on Wednesday in the journal PLoS One, and a professor of genetics and nutrition at the Pennington Biomedical Research Center, part of the Louisiana State University system.
Dr. Michael Lauer, director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute, the lead federal research institute on heart disease and strokes, was among the experts not involved in the provocative study who applauded it. “It is an interesting and well-done study,” he said.
Others worried about its consequences.
“There are a lot of people out there looking for any excuse not to exercise,” said William Haskell, emeritus professor of medicine at the Stanford Prevention Research Center. “This might be an excuse for them to say, ‘Oh, I must be one of those 10 percent.’ ”
But counterbalancing the 10 percent who got worse were about the same proportion who had an exaggeratedly good response on at least one measure. Others had responses ranging from little or no change up to big changes, seen in about 10 percent, where risk factor measurements improved anywhere from 20 percent to 50 percent.
“That should make folks happy,” said Dr. William E. Kraus, a co-author of the study who is a professor of medicine and director of clinical research at Duke. He was a member of the committee providing the scientific overview for the Department of Health and Human Services’ national exercise guidelines, which advise moderate exercise for at least 150 minutes a week.
The problem with studies of exercise and health, researchers point out, is that while they often measure things like blood pressure or insulin levels, they do not follow people long enough to see if improvements translate into fewer heart attacks or longer lives. Instead, researchers infer that such changes lead to better outcomes — something that may or may not be true.
Some critics have noted that there is no indication that those who had what Dr. Bouchard is calling an adverse response to exercise actually had more heart attacks or other bad health outcomes. But Dr. Bouchard said if people wanted to use changes in risk factors to infer that those who exercise are healthier, they could not then turn around and say there is no evidence of harm when the risk factor changes go in the wrong direction.
“You can’t have it both ways,” Dr. Bouchard said.
The national guidelines for exercise are based on such inferences and also on studies that compared the health of people who exercised with that of people who did not, a weak form of evidence often said to be hypothesis-generating rather than proof.
“We do not know whether implementing exercise programs for unfit people assures better outcomes,” said Dr. Lauer of the heart institute. “That has not been established.” And so, he said, “there is a lot of debate over how strong the guidelines should be in light of weak evidence.”
Authors of the study say people should continue to exercise as before, but might also consider getting their heart disease risk factors checked on a regular basis. No intervention, including drugs, works for everyone, Dr. Kraus said. So it should not be surprising that exercise does not work for some.
“I am an exercise guy; I believe in exercise for health,” Dr. Kraus said. “I would rather have everyone exercise. But you can’t ignore the data.”
Still, he added, even if someone does not get the expected benefit in some heart risk factors, there are other reasons to exercise: for mental health and to improve physical functioning.
And while the researchers would like to spare people from adverse exercise effects, Dr. Bouchard said, “It is not possible yet to make more specific recommendations because we do not understand why this is happening.”
Dr. Bouchard stumbled upon the adverse exercise effects when he looked at data from his own study that examined genetics and responses to exercise. He noticed that about 8 percent seemed to be getting worse on at least one measure of heart disease risk. “I thought that was potentially explosive,” he said.
He then looked for other clinical trials that also examined exercise under controlled conditions, making sure that participants actually exercised and did not change their diets, and carefully measuring heart risk factors and how they changed with an exercise program. He found five studies in addition to his own. In all the studies, a proportion of people, about 10 percent, had at least one measurement of heart disease risk that went in the wrong direction.
Then the researchers asked if there was some way of predicting who would have an adverse effect.
They found it was not related to how fit the people were at the start of the study, nor to how much their fitness improved with exercise. Age had nothing to do with it, nor did race or gender. In some studies subjects were allowed to take medications to control their blood pressure or cholesterol levels. In others they were not.
Medication use did not matter. The study subjects exercised at a range of intensities from very moderate to fairly intense. But intensity of effort was not related to the likelihood of an untoward effect. Nothing predicted who would have an adverse response.
Some experts, like Dr. Benjamin Levine, a cardiologist and professor of exercise sciences at the University of Texas Southwestern Medical Center, asked whether the adverse responses represented just random fluctuations in heart risk measures. Would the same proportion of people who did not exercise also get worse over the same periods of time? Or what about seasonal variations in things like cholesterol? Maybe the adverse effects just reflected the time of year when people entered the study.
But the investigators examined those hypotheses and found that they did not hold up.
Dr. Kraus said researchers needed to figure out how to tailor exercise prescriptions to individual needs. For example, people with good cholesterol and insulin levels but worrisome blood pressure would want to know if exercise made their blood pressure rise. A rise in blood pressure would not be compensated by improvements in already good cholesterol or insulin levels.
Dr. Lauer said that if nothing else, the study pointed out the need to know more about what exercise actually does. “If we are going to think of exercise as a therapeutic intervention, like all interventions there will be adverse effects,” he said.
He said, “There is a price for everything.”
source: nytimes.com
Monday, February 20, 2012
Diet soda tied to heart attack, stroke risks: study

The study, which followed almost 2,600 older adults for a decade, found that those who drank diet soda every day were 44 percent more likely than non-drinkers to suffer a heart attack or stroke.
The findings, reported in the Journal of General Internal Medicine, don't prove that the sugar-free drinks are actually to blame.
There may be other things about diet-soda lovers that explain the connection, researchers say.
"What we saw was an association," said lead researcher Hannah Gardener, of the University of Miami Miller School of Medicine. "These people may tend to have more unhealthy habits."
She and her colleagues tried to account for that, Gardener told Reuters Health.
Daily diet-soda drinkers did tend to be heavier and more often have heart risk factors like high blood pressure, diabetes and unhealthy cholesterol levels.
That all suggests that people who were trying to shed pounds or manage existing health problems often opted for a diet soda over the sugar-laden variety.
But even after the researchers factored in those differences -- along with people's reported diet and exercise habits -- they found that daily diet soda was linked to a 44-percent higher chance of heart attack or stroke.
Nevertheless, Gardener said, it's impossible for a study to capture all the variables that could be at work.
The findings do build on a few recent studies that also found diet-soda drinkers are more likely to have certain cardiovascular risk factors, like high blood pressure or high blood sugar.
This is the first study, Gardener said, to look at actual "vascular events" -- that is, heart attacks, strokes and deaths from cardiovascular causes.
The findings are based on 2,564 New York City adults who were 69 years old, on average, at the outset. Over the next decade, 591 men and women had a heart attack, stroke or died of cardiovascular causes.
That included 31 percent of the 163 people who were daily diet-soda drinkers at the study's start. In contrast, 22 percent of people who rarely or never drank diet soda went on to have a heart attack or stroke.
There was no increased risk linked to less-than-daily consumption. Nor was regular soda tied to heart attacks and strokes.
If diet soda, itself, somehow contributes to health risks, it's not clear how, Gardener said.
There's research in rats suggesting that artificial sweeteners can end up boosting food intake and weight. But whether results in rodents translate to humans is unknown.
"I don't think people should change their behavior based on this study," Gardener said. "And I wouldn't advocate drinking regular soda instead."
Regular soda is high in calories, and for people who need to shed pounds, experts often suggest swapping regular soda for the diet version.
A study out this month found that the advice may be sound. Obese people who were randomly assigned to drink water or diet drinks in place of sugary ones lost about five pounds over six months.
Gardener said that further studies such as hers are still needed to confirm a connection between diet soda and cardiovascular trouble.
Ultimately, she noted, clinical trials are considered the "gold standard" for proving cause-and-effect. That would mean randomly assigning people to drink diet soda or not, and then following them over time to see if there were differences in their rates of heart problems or stroke.
A study like that, Gardener said, would be "difficult and costly" -- since it would have to follow large groups of people over many years, and rely on people to stick with their assigned beverages.
article source: mb.com.ph